Sunshine Biopharma closes $6 million public offering, issues Series D warrants for up to $14.4 million proceeds

Bitget2026/10/09 15:17

Sunshine Biopharma closed a public offering raising about $6 million in gross proceeds. Deal included 10,909,082 common units or pre-funded units priced at $0.55 per unit. Each unit carried two Series D warrants with a $0.66 exercise price, exercisable immediately with a five-year term. Full cash exercise of the Series D warrants could raise about $14.4 million in additional gross proceeds. Net proceeds earmarked for general corporate purposes and working capital. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sunshine Biopharma Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202610091117ACCESSWRNAPR_____1235050) on October 09, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Dow Jones Top Energy Headlines at 12 AM ET: Oil Futures Slide As Market Holds Out Hopes for Middle East Diplomacy | Energy ...

Dow Jones•2026/11/09 05:00

United States Dollar Index remains subdued as lower oil prices ease inflation pressure

FXStreet•2026/11/09 04:54

Citi is bullish on the Indian stock market, expecting the Nifty Index to rise to 28,000 points by the end of 2027.

路透社•2026/11/09 04:06

Silver Price Forecast: XAG/USD rises to near $53.00 as lower oil eases inflation pressure

FXStreet•2026/11/09 03:39